ATLANTA (MedPage Today) -- An investigational agent won't slow progression of chronic kidney disease in type 2 diabetes patients, and may cause cardiovascular harm, researchers reported here. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment